CS logo
small CS logo
CHU Henri Mondor; Service d'Oncologie Medicale

Creteil, France
General hospital in Créteil
1 Rue Gustave Eiffel, 94000 Créteil

About CHU Henri Mondor; Service d'Oncologie Medicale


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at CHU Henri Mondor; Service d'Oncologie Medicale


During the past decade, CHU Henri Mondor; Service d'Oncologie Medicale conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Anti-Androgen Treatment for COVID-19
2020-10-21
2021-01-21
Completed
268
EAT-DUTA AndroCoV Trial
2020-06-30
2020-10-07
Completed
138
Proxalutamide Treatment for COVID-19 Female Outpatients
2020-11-01
2021-12-01
Withdrawn
0
The South Proxa-Rescue AndroCoV Trial Against COVID-19
2021-03-06
2021-04-15
Completed
133

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at CHU Henri Mondor; Service d'Oncologie Medicale


According to Clinical.Site data, the most researched conditions in "CHU Henri Mondor; Service d'Oncologie Medicale" are "Colorectal Cancer" (2 trials), "B-cell Non-Hodgkin Lymphoma" (1 trials), "Bladder Cancer" (1 trials), "Breast Cancer" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "CHU Henri Mondor; Service d'Oncologie Medicale" in a lesser frequency.

Clinical Trials Intervention Types at CHU Henri Mondor; Service d'Oncologie Medicale


Most popular intervention types in "CHU Henri Mondor; Service d'Oncologie Medicale" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at CHU Henri Mondor; Service d'Oncologie Medicale


The vast majority of trials in "CHU Henri Mondor; Service d'Oncologie Medicale" are 5 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at CHU Henri Mondor; Service d'Oncologie Medicale


Currently, there are NaN active trials in "CHU Henri Mondor; Service d'Oncologie Medicale". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in CHU Henri Mondor; Service d'Oncologie Medicale, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CHU Henri Mondor; Service d'Oncologie Medicale, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status